nejm semaglutide heart failure Patients with type 2 #diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. ⁣ ⁣ Whether treatment with would mitigate these risks is unknown. ⁣ ⁣ SELECT Trial

The mechanism of action centres on mimicking a naturally occurring hormone called GLP-1, which is released from the intestine after eating

modelling, visual predictive checks over each trial and across trials, mean model predictions across trial arms and individual fits over time

Youve likely heard about Tirzepatide (Mounjaro, Zepbound) as well

GLP-1RAs Are Uniquely Compelling for Addiction Treatment and Prevention I started prescribing it for this use about a year and a half ago, so far I've prescribed it to maybe a dozen patients just for this reason

This class of drugs has dramatically changed diabetes care

This issue of scale creates an opening for AI-based companion products that provide supplemental support based on a specialists advice